CanSino Biologics Inc. (CASBF) Financials
CASBF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.0 billion | 243.1 million |
| March 31, 2026 | 1.0 billion | 297.6 million |
| Dec. 31, 2025 | 1.0 billion | 288.0 million |
| Sept. 30, 2025 | 1.0 billion | 332.7 million |
CASBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -4.8 million | ? |
| March 31, 2026 | -12.8 million | ? |
| Dec. 31, 2025 | 1.2 million | ? |
| Sept. 30, 2025 | -2.1 million | ? |
CASBF Net Income
No data available :(
CASBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 271.4 million | 132.5 million | 1.4 million |
| March 31, 2026 | 300.0 million | 136.3 million | 1.0 million |
| Dec. 31, 2025 | 378.1 million | 136.8 million | 1.9 million |
| Sept. 30, 2025 | 346.4 million | 147.6 million | 1.2 million |
CASBF Shares Outstanding
CASBF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4.0 million | 9.4 million | 23.4 million | - |
| March 31, 2026 | 4.5 million | 10.2 million | 17.3 million | - |
| Dec. 31, 2025 | 9.3 million | 1.4 million | 3.7 million | - |
| Sept. 30, 2025 | 6.5 million | 10.8 million | 22.1 million | - |
CASBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 52.7 million | 16.9 million |
| March 31, 2026 | 27.3 million | 5.2 million |
| Dec. 31, 2025 | 52.9 million | 29.2 million |
| Sept. 30, 2025 | 43.5 million | 9.4 million |
CASBF
Price: $4.90
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.02 USD
P/E Ratio: 230
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.4 billion